These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22714121)

  • 1. Neural changes associated with appetite information processing in schizophrenic patients after 16 weeks of olanzapine treatment.
    Stip E; Lungu OV; Anselmo K; Letourneau G; Mendrek A; Stip B; Lipp O; Lalonde P; Bentaleb LA
    Transl Psychiatry; 2012 Jun; 2(6):e128. PubMed ID: 22714121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal correlates of appetite regulation in patients with schizophrenia: is there a basis for future appetite dysfunction?
    Lungu O; Anselmo K; Letourneau G; Mendrek A; Stip B; Lipp O; Lalonde P; Ait Bentaleb L; Stip E
    Eur Psychiatry; 2013 Jun; 28(5):293-301. PubMed ID: 22542330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients.
    Smith RC; Rachakonda S; Dwivedi S; Davis JM
    Psychiatry Res; 2012 Oct; 199(3):159-63. PubMed ID: 22475524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine increases plasma ghrelin level in patients with schizophrenia.
    Murashita M; Kusumi I; Inoue T; Takahashi Y; Hosoda H; Kangawa K; Koyama T
    Psychoneuroendocrinology; 2005 Jan; 30(1):106-10. PubMed ID: 15358448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia.
    Hosojima H; Togo T; Odawara T; Hasegawa K; Miura S; Kato Y; Kanai A; Kase A; Uchikado H; Hirayasu Y
    J Psychopharmacol; 2006 Jan; 20(1):75-9. PubMed ID: 16204328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body weight and plasma levels of ghrelin and leptin during treatment with olanzapine.
    Kim BJ; Sohn JW; Park CS; Hahn GH; Koo J; Noh YD; Lee CS
    J Korean Med Sci; 2008 Aug; 23(4):685-90. PubMed ID: 18756058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of appetite in predicting weight changes during treatment with olanzapine.
    Case M; Treuer T; Karagianis J; Hoffmann VP
    BMC Psychiatry; 2010 Sep; 10():72. PubMed ID: 20840778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin and leptin levels in patients with schizophrenia or related psychoses--a comparison between different antipsychotic agents.
    Melkersson KI; Hulting AL
    Psychopharmacology (Berl); 2001 Mar; 154(2):205-12. PubMed ID: 11314683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased levels of ghrelin, cortisol, and fasting blood sugar, but not n-octanoylated ghrelin, in Japanese schizophrenic inpatients treated with olanzapine.
    Tanaka K; Morinobu S; Ichimura M; Asakawa A; Inui A; Hosoda H; Kangawa K; Yamawaki S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1527-32. PubMed ID: 18571822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study.
    Poyurovsky M; Fuchs C; Pashinian A; Levi A; Faragian S; Maayan R; Gil-Ad I
    Psychopharmacology (Berl); 2007 Jun; 192(3):441-8. PubMed ID: 17310385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salience network and olanzapine in schizophrenia: implications for treatment in anorexia nervosa.
    Stip E; Lungu OV
    Can J Psychiatry; 2015 Mar; 60(3 Suppl 2):S35-9. PubMed ID: 25886678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review.
    Sentissi O; Epelbaum J; Olié JP; Poirier MF
    Schizophr Bull; 2008 Nov; 34(6):1189-99. PubMed ID: 18165262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antipsychotics on peptides involved in energy balance in drug-naive psychotic patients after 1 year of treatment.
    Perez-Iglesias R; Vazquez-Barquero JL; Amado JA; Berja A; Garcia-Unzueta MT; Pelayo-Terán JM; Carrasco-Marín E; Mata I; Crespo-Facorro B
    J Clin Psychopharmacol; 2008 Jun; 28(3):289-95. PubMed ID: 18480685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.
    Citrome L; Holt RI; Walker DJ; Hoffmann VP
    Clin Drug Investig; 2011; 31(7):455-82. PubMed ID: 21495734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B
    J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin.
    Lu ML; Wang TN; Lin TY; Shao WC; Chang SH; Chou JY; Ho YF; Liao YT; Chen VC
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():47-50. PubMed ID: 25496829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Betahistine effects on weight-related measures in patients treated with antipsychotic medications: a double-blind placebo-controlled study.
    Smith RC; Maayan L; Wu R; Youssef M; Jing Z; Sershen H; Szabo V; Meyers J; Jin H; Zhao J; Davis JM
    Psychopharmacology (Berl); 2018 Dec; 235(12):3545-3558. PubMed ID: 30382354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
    Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
    Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of second generation antipsychotics on leptin and ghrelin.
    Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses.
    Melkersson KI; Hulting AL; Brismar KE
    J Clin Psychiatry; 2000 Oct; 61(10):742-9. PubMed ID: 11078035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.